http://rdf.ncbi.nlm.nih.gov/pubchem/patent/ES-2316763-T3
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a7dffbd04747d5d9b9492e7f2ac61db6 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D311-86 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12P17-181 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D493-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D493-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D493-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-06 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-74 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D493-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P17-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P17-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D311-86 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-352 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D493-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D493-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-357 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D493-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D493-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-35 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D519-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-062 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 |
| filingDate | 2003-01-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2009-04-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_86bd4fdbe422885a0912324e0d879169 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_610d51c0dc527b2228f4c74bdc502b09 |
| publicationDate | 2009-04-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | ES-2316763-T3 |
| titleOfInvention | COMPOUNDS AS SEMAPHORINE INHIBITORS. |
| abstract | Compound represented by the general formula (1): (see formula) in which R1, R2, R3 and R4 represent one of the following [I] to [IX]: [I] R1 represents a hydrogen atom or a carboxyl group , R2 represents a hydrogen atom or a hydroxyl group, and R3 and R4, join to form a divalent group of formula (2) :( see formula) in which R5 represents a hydrogen atom or a carboxyl group and R6 represents a hydrogen atom or a hydroxyl group; [II] R1 represents a hydrogen atom or a carboxyl, R2 represents a hydrogen atom or a hydroxyl group, and R3 and R4, join to form a divalent group of formula (3): (see formula) in which R5 and R6 have the same meanings as before; [III] R1 represents a hydrogen atom or a carboxyl group, R2 represents a hydrogen atom or a hydroxyl group, and R3 and R4, join to form a divalent group of formula (4) :( see formula) in which R5 and R6 have the same meanings as before; [IV] R 1 represents a hydrogen atom or a carboxyl group, R 2 represents a hydrogen atom or a hydroxyl group, and R 3 and R 4, join to form a divalent group of formula (5): (see formula ) in which R 5 and R 6 have the same meanings as before; [V] R 1 represents a hydrogen atom or a carboxyl group, R 2 represents a hydrogen atom or a hydroxyl group, R 3 represents a hydrogen atom and R 4 represents a group of formula (6): (see formula) [VI] R 1 represents a hydrogen atom or a carboxyl group, R 2 represents a hydrogen atom or a hydroxyl group and R 3 and R 4 join to form a divalent group of formula (7): (see formula) in which R 5 and R 6 have the same meanings as before; [VII] R 1 represents a hydrogen atom or a carboxyl group, R 2 represents a hydrogen atom or a hydroxyl group and R 3 represents a group of formula (8): (see formula) in which R 7 represents an atom of hydrogen or a carboxyl group and R 8 represents a hydrogen atom or a hydroxyl group and R 4 represents a group of formula (9); (see formula) in which R 5 represents a carboxyl group, and R 6 has the same meaning as before; [VIII] R 1 represents a carboxyl group, R 2 represents a hydroxyl group, and R 3 and R 4 join to form a divalent group of formula (10): (see formula) in which R 5 represents a carboxyl group and R 6 represents a hydroxyl group; [IX] R 1 represents a carboxyl group; R 2 represents a hydroxyl group, and R 3 and R 4 join to form a divalent group of formula (11): (see formula) or a pharmaceutically acceptable salt thereof. |
| priorityDate | 2002-01-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 115.